POLD1 and endometrial cancer: Despite multiple reports of germline POLD1 variants involving changes in the DEDD motif in both colorectal and endometrial cancer patients [9,28,29,30], this mutation class is still classified as VUSs by laboratory submitters in the ClinVar database, rendering these variants clinically inactionable.